Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nexium Capsules Specific Clinical Experience Investigation for Maintenance Therapy for Repeatedly Recurring/Relapsing Reflux Oesophagitis

NCT01562639 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01562639
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01562639 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nexium Capsules Specific Clinical Experience Investigation for Maintenance Therapy for Repeatedly Recurring/Relapsing Reflux Oesophagitis
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
April 30, 2012
Completion date
July 31, 2014
Enrollment
647 (actual)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

relapsing reflux esophagitis, repeatedly recurring esophagitis